BS

Benny Sorensen

Chief Executive Officer

Hemab Therapeutics

Cambridge, Massachusetts


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
Hemab Therapeutics
Industry
research
Employees
61.0
Seniority
C suite
Annual Revenue
4000000.0
Total Funding
190000000.0
Latest Funding
Series B

Technologies

Outlook Microsoft Office 365 Google Cloud Hosting Nginx WordPress.org Google Tag Manager Mobile Friendly Typekit Remote

Keywords

biotech biotechnology research hemab bleeding disorders thrombotic disorders prophylactic treatments therapeutic solutions bispecific antibody hmb-001 clinical trials factor vii deficiency glanzmann thrombasthenia von willebrand disease functional cures endogenous clotting factors hemostatic plugs safety & efficacy monoclonal antibodies lifesaving therapies patient care innovative treatments orphan drug designation blood clotting medical research rare diseases high unmet need clinical evaluation advanced technologies drug discovery biologics preventive medicine treatment paradigm hemophilia b hereditary hemorrhagic telangiectasia congenital antithrombin iii deficiency recruitment of factors pharmacodynamics pharmacokinetics subcutaneous administration dose-dependent response high affinity therapeutic levels phase 2 study patient engagement clinical endpoints sustained efficacy therapeutic innovation medical advancements rare clotting disorders treatment gaps social impact quality of life improvement health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans